Form 4: Mobix Labs Director Frederick Goerner Sells Shares and Holds Options

Director Frederick Goerner sold 5,020 shares of Mobix Labs, Inc. at an average price of $1.3507 and holds options to purchase 153,416 shares.

Summary

• On February 21, 2025, Frederick Goerner, a director of Mobix Labs, Inc., sold 5,020 shares of Class A Common Stock at a weighted average price of $1.3507.
• The sale price ranged from $1.35 to $1.355 per share.
• Following the transaction, Goerner directly owns 255,169 shares of Class A Common Stock.
• Goerner also holds options to buy 20,000 shares at $4.18, exercisable until August 10, 2030, and 133,416 shares at $6.84, exercisable until April 4, 2032.
• These options are fully vested and exercisable.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a director's stock sale and option holdings. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the buying and selling activities of company directors. It's common for directors to have stock options and to periodically exercise or sell shares.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• The information provided is consistent with the level of detail expected in such filings, similar to those of directors at comparable companies like Himax Technologies or Ambarella.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the overall effect is likely minimal given the relatively small number of shares sold.
• The disclosure provides transparency to stakeholders regarding insider transactions.

Key Dates